Experimental autoimmune uveitis, a well-established model for human uveitis, is similar to human uveitis in many pathological features. Studies concerning the mechanisms of experimental autoimmune uveitis would cast a light on the pathogenesis of human uveitis as well as the search for more effective therapeutic agents. The cellular components of innate immunity include natural killer cells, gamma delta T lymphocytes, antigen-presenting dendritic cells, phagocytic macrophages, and granulocytes. It is believed that T cells are central in the generation of human uveitis. It has already become clear that CD4
Introduction
Uveitis, an inflammatory disease that potentially causes blindness, presents a therapeutic challenge for all ophthalmologists. Knowledge of the classification and etiology of uveitis is important for the diagnosis and treatment of the disorder. The human body is often in routine contact with all kinds of pathogens, but it does not become diseased or ill, which is reflected in innate immunity. The adaptive immunity, distinguishing the foreign pathogens from the body, is able to maintain the integrity of the immune system and make appropriate responses to the peripheral environment. Dysfunction of innate and adaptive immune systems can result in unregulated, inappropriate, and detrimental autoimmune disease including uveitis. In this article, we will review an animal model of uveitis, the different roles of innate immunity and adaptive immunity, together with their interplay in the pathogenesis of uveitis.
Experimental autoimmune uveitis model is an effective and suggestive means for uveitis research
Uveitis, a common cause of visual impairment and blindness, is an autoimmune disorder predominantly mediated by T helper cells, 1 and is associated with chronic and recurrent ocular complications. 2 The annual incidence rate of uveitis varies between 17 cases and 52 cases per 100,000, and its prevalence varies between 69 cases and 204 cases per 100,000 populations. 3 In developed countries, uveitis affects approximately 200 per 100,000 in the population, and uveitis and its complications account for up to 35% of severe visual impairment. 4 Uveitis is the third leading cause of blindness Conflicts of interest: The authors declare that there are no conflicts of interest related to the subject matter or materials discussed in this article.
among Americans, where its prevalence is 204 per 100,000 persons per year. 5 In less developed countries, uveitis and its complications are even more common, affecting an estimated 714 per 100,000 and contributing to 25% of blindness. 4 Consequently, it poses a heavy burden on society and the family. 6 According to the different anatomic locations of the inflammation, uveitis is classified as anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis. Anterior uveitis is the most common type, constituting 50e92% of all types in Western countries and 28e50% in Asia. 7 Intermediate uveitis is primarily idiopathic and bilateral in childhood and adult groups, and accounts for 6% of all uveitis cases observed over a period of 16 years. 8 Posterior uveitis is thought to comprise approximately 5% of all uveitis entities. 4 Acute anterior uveitis is a common ocular inflammatory disease that can cause severe visual impairment. In addition to recurrence, acute anterior uveitis may lead to sight-threatening complications such as cataract, macular edema, and glaucoma. 9 The intermediate and posterior uveitis are associated with a group of ocular disorders characterized by inflammation of the choroid, retina, retinal vessels, vitreous, or ciliary body that may occur in isolation, as part of a panuveitis, or in conjunction with systemic disease. 10 The vast majority of cases of uveitis are caused by autoimmune response. There are animal models of uveitis (Table  1) 20, 52, 53 . However, because human pathology specimens have been unavailable, experimental autoimmune uveitis (EAU) has been established in vivo.
11 EAU is a mature animal model that can mimic human uveitis. 12 It can be manipulated by immunization with several retinal autoantigens, of which retinal S-antigen (S-Ag) and interphotoreceptor retinoid binding protein (IRBP) are featured (Tables 2 and 3) 15,54e61 . Unfortunately, most of these models display an acute and monophasic disease course with spontaneous recovery, raising questions about how well laboratory observations acquired from such studies reflect the actual situation in the human disease. Because recurrent uveitis poses the highest risk for ocular complications in human disease that could cause blindness, availability of a chronic and/or relapsing animal model would be most helpful for dissecting the disease pathogenesis. A chronic recurrent uveitis model was induced in the Lewis rat by adoptive transfer of T cells specific for IRBP peptide (sequence of 1177e1191 of bovine IRBP protein, R16). 13, 14 The disease is characterized by a chronic recurrent pattern of uveitis, with an unpredictable frequency and duration of remission and relapses. 14 The clinical symptoms started 3e5 days after transfer, and manifested in multiple episodes, each lasting 1e7 days, followed by varying periods of remission. Neither the duration of a single disease peak nor the interval between episodes was predictable. In addition, the right and left eyes of a single recipient often showed a different rhythm of relapse, similar to the situation often seen in the human disease. Given that a large number of transgenic and knockout mice are available on the C57BL/6 background, many studies have chosen to use the C57BL/6 mouse. Unfortunately, C57BL/6 mice only develop very weak EAU after immunization with IRBP1e20. The induced disease occurred at a low incidence with mild inflammation and a short duration (average score of 0.5 out of maximal 4). 15, 16 The availability of a reproducible model of uveitis in the C57BL/6 mouse is particularly desirable. When T cells are isolated from the immunized mice and adoptively transferred to a naïve C57BL/ 6 mouse, the recipient develops a much more severe disease, with an average score of 2e3 and duration of at least 60 days. Similar to relapsing uveitis in Lewis rat, the incidence, severity, and duration of disease were dependent on the number and activation status of the injected T cells. 17 In Table 1 Major animal models of uveitis.
Animals and types of model Examples of models Characters Refs
Rat addition, R161H mice can develop a high incidence of moderate to severe spontaneous uveitis pathology by 2e3 months of age. 18 Autoimmune regulator deficient (AIRE À/À ) mice can induce EAU. 19 Moreover, spontaneous mice can develop a chronic-progressive disease, with a significant recovery of visual function compared with IRBP-immunized B10.RIII mice. 20 The clinical heterogeneity of uveitis as well as the finding of different pathological patterns suggest that uveitis may be a spectrum of diseases that may represent different pathological processes.
Pathogenesis of innate immunity in uveitis
Innate immunity is an evolutionarily conserved defense mechanism capable of fighting a diverse threat of viral, prokaryotic, and eukaryotic parasites and pathogens in plants and invertebrate animals. 21 An innate immune system provides an immediate host immune response to infectious agents and relies on the expression of germline-encoded receptors for their detection. 22 A variety of circumstantial observations suggest that the innate immune system is very important in the development of uveitis.
Natural killer T lymphocytes (natural killer T cells)
Natural killer T (NKT) cells are a heterogeneous population of unconventional T cells that express markers of NK cells and T cell receptors (TCRs) and possess some of the properties of NK cells and T cells, and are also a kind of specific T lymphocyte subset. NKT cell subsets with different functions exist in humans and mice, including classical (type I) invariant and other CD1d-dependent (type II) NKT cells, and also CD1d-independent (NKT-like) T cells. 23 NKT cells are more prevalent in the liver than in other organs, comprising up to 30% of the intrahepatic lymphocytes in mice. 24 The stability of NKT cells plays a role in the control of various autoimmune diseases. Recently, it has been observed that NKT cells present a wide range of responses in their involvement in regulating the human immune system. 25 NKT cells have also been shown to have the ability to resist the virus and tumor, and contribute to the regulation of autoimmune diseases. 26 Innate immune cells, NKT cells, and macrophages not only influence inflammatory tissue damage but also participate in T lymphocyte responses to induce uveitis. 27 There is an increasing amount of evidence showing that NKT cells are involved in the regulation of the adaptive immune response as well. 28 In our previous study, we explored the diverse roles of NKT cells in the liver and spleen and found that liver-derived NKT cells could efficiently inhibit Th1 and Th17 differentiation, whereas the function of spleen-derived NKT cells was less potent. Meanwhile, the occurrence of the peak ratios of NKT cells/T cells in the spleen and liver was markedly asynchronous after immunization. Moreover, different methods of immunization could result in different immune responses in mice. Furthermore, the memory response was also found in the generation of NKT cells in mice when they received the same antigen. These results indicated that there is diversity in the functional roles of NKT cells in the spleen and liver in mice with EAU. 29 
Gamma delta T lymphocytes
Gamma delta T cells were first described as peripheral blood lymphocytes expressing CD3
þ , a commonly used T cell marker, but not alpha beta TCRs. Gamma delta T cells possessing surface receptors are a unique phenotype and the main function of lymphocyte subsets in innate immunity. 30 Studies have shown that gamma delta T cells act to "bridge the gap" between innate and adaptive immunity 31 or to regulate the intensity of the adaptive immune response. 32 There is also evidence that different gamma delta T cell subsets have different immunoregulatory effects. 33, 34 It has been shown that in vitro activation of IRBP-specific T cells from C57BL/6 mice immunized with an uveitogenic IRBP peptide (IRBP1e20) under Th17-polarizing conditions is associated with increased expansion of T cells expressing the gamma delta TCR. It has also been shown that highly purified alpha beta or gamma delta T cells from C57BL/6 mice immunized with IRBP1e20 produced only small amounts of interleukin (IL)-17 after exposure to the immunizing Ag in vitro, whereas a mixture of the same T cells produced significantly increased amounts of IL-17. IRBP-induced T cells from IRBPimmunized TCR-delta À/À mice on the C57BL/6 genetic background produced significantly lower amounts of IL-17 than did wild-type C57BL/6 mice and had significantly decreased EAU-inducing ability. However, reconstitution of the TCR-delta À/À mice prior to immunization with a small number of gamma delta T cells from IRBP-immunized C57BL/6 mice restored the disease-inducing capability of their IRBP-specific T cells and greatly enhanced the generation of IL-17 þ T cells in the recipient mice. Our study suggests that gamma delta T cells are important in the generation and activation of IL-17-producing autoreactive T cells and play a major role in the pathogenesis of EAU. 35 There are some cells and proteins in the body that are involved in uveitis of innate immunity, for example, dendritic cells, 36 macrophages, 16 complement, 37 and TLRs 38 (Table  4) 27,29,33,36e38 .
Etiology of adaptive immunity in uveitis
The mechanism of adaptive immunity has added to the human immune system a specific recognition of carbohydrates, lipids, pathogenic proteins, and nucleic acids in its effort to mount an immune defense and defy their evasion strategies and attack against the ever-growing pool of disorders. 21 The uveitogenic T cells that mediate EAU were commonly assumed to be exclusively CD4
þ . The involvement of both CD4 and CD8 autoreactive T cells in autoimmune diseases has been well established recently. Recent studies have also shown that a specific autoreactive T cell subset that produces IL-17, but not interferon (IFN)-g or IL-4, is crucially involved in the pathogenesis of autoimmune diseases. We try to illustrate the uveitogenic role of CD8 and IL-17 þ uveitogenic T cells.
CD8 uveitogenic T cells

CD4
þ are commonly proposed to be exclusive in the uveitogenic T cells that modulate EAU. Our data revealed that even if all the long-term cultured uveitogenic T cell of rat lines particularly for R16 expressed CD4, as many as 40% of the freshly prepared R16-specific uveitogenic T cells from Agimmunized rats were CD8 þ alpha beta TCR þ . The CD8 T cells were highly purified and antigen-specific CD8 þ R16-specific T cells that were capable of producing uveitis by means of transfusion into naive rats. Furthermore, compared to their CD4 þ counterparts, CD8 þ uveitogenic T cells were more fully prepared to switch phenotype to or from TCR À
CD8
À CD4 À when they were activated in vivo or in vitro. 39 Autoreactive CD8 T cells were also abundant in B10.RIII mice, an EAU-susceptible strain, immunized with the uveitogenic peptide IRBP161e180. 40 Different from CD4 autoreactive T cells, the growth factors produced by activated CD8 autoreactive T cells were rather limited. 41 For this reason, the activation and expansion CD8 T cell would be aborted in the absence of exogenously supplied growth factor(s), whereas the growth and expansion of triggered CD8 autoreactive T cells could be supported by a series of cytokines. Besides the factors produced by activated CD4 autoreactive T cells, other factors produced by nonlymphoid cells (e.g., IL-7, IL-15), retinal pigment epithelial (RPE) cells, as well as unidentified factors in the culture supernatants of astrocytes were capable of supporting the CD8 autoreactive T cells as well. Even though the response of CD8 T cell in vitro could be augmented by several cytokines, different cytokines seem to act on different CD8 subsets or activation/differentiation phases of CD8 autoreactive T cells. For this reason, cytokines, such as IL-7, were proposed to support the proliferation and survival of CD8 IRBP-specific T cells, whereas others only had a growth-promoting effect.
Additionally, a previous study, by which the role of the CD8 IRBP-specific T cells in the etiology of EAU could be further corroborated, demonstrated that the susceptibility of the b2-microglobulin À/À mouse to the induction of EAU by adoptive transfer of IRBP-specific T cells from C57BL/6 mice was substantially decreased. 42 
IL-17
þ uveitogenic T cells
Recent investigations have shown that a specific autoreactive T cell subset that produces IL-17 instead of IFN-g and IL-4, played a key role in the etiology of autoimmune disorders, including experimental autoimmune encephalomyelitis, rheumatoid arthritis, and other allergic diseases, especially in the chronic phase. 43e45 In order to determine the role of IL-17 þ T cells in the generation of EAU and the interrelationship between previously characterized uveitogenic T cell subsets and IL-17 þ T cells, we investigated the involvement and the pathologic function of IL-17 þ T cells in EAU. By making a comparison of the pathogenic effect between IL-17 þ and nonspecific IL-17 þ T cells specific for the uveitogenic antigen, the event whether IL-17 was expressed by CD4 autoreactive T cells exclusively or by CD8 autoreactive T cells, which we were even more interested in, was further determined. Our data revealed that, in EAU, the capability of CD4 and CD8 autoreactive T cells were equal in expressing IL-17. IL-17 
Interplay of innate and adaptive immunity in uveitis
Many of the diseases that afflict mankind are now thought to be the result of dysfunctional innate and/or adaptive immune responses. 49 In some cases, the adaptive immune elements restrain innate immune responses. In other cases, the combination of innate and adaptive immunity maximizes the host defense while minimizing collateral damage to the host tissues. Innate immunity generates help signals in the damaged tissues, whereas adaptive immunity provides specific responses to the insult that directly attack the pathogenic process or recruit other powerful innate effector cells that, although not specific by themselves, can act specifically by their selective recruitment. 21 Little is actually known about innate-adaptive connections. 50 However, the mechanisms by which the innate immune system instructs and directs adaptive immune responses are becoming increasingly clear. 51 Interactions between innate and adaptive immunity can result in harmful immunologic responses. 51 The nexus of the innate and adaptive systems involves many secrets even now, and both innate and adaptive immunologists are finally united in their desire to uncover them, working across a gap that is ever narrowing. 50 It is clear from the discussion in this section that further evaluation of the relationship between the innate and the adaptive arms of the immune system will provide a significantly deeper insight into the mechanisms of uveitis as well as result in better therapeutic approaches.
Future perspectives
In this article, we have introduced important components of an animal model of uveitis. EAU is an excellent animal model for studying the pathogenesis of autoimmune diseases. Better understanding of the pathogenesis of uveitis may help clinicians manage patients with inflammatory ocular diseases, and further enable different uveitis entities to be effectively compared.
EAU is regarded as an acute, monophasic disease. Although EAU models help to shed light on the mechanisms driving human disease, it is impossible to comprehensively imitate human uveitis. Therefore, it is necessary to establish a far better model to mimic human uveitis. The role of Th17 and IL-17 in the pathogenesis of uveitis remains undefined in some aspects. The innate and adaptive immune systems form one integrated defense network. The interplay between the two systems will become more meaningful when their mechanisms are identified completely. EAU has also served as a useful template for novel therapeutic approaches. By focusing on EAU, different pathogenesis points provide clinicians with some valid therapeutic targets for human uveitis. However, continuation of the study would allow us to obtain muchneeded information for designing new and better therapies for control and cure of such diseases.
